Burning Rock Biotech (BNR) Non-Current Receivables (2020 - 2024)
Historic Non-Current Receivables for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2024 value amounting to $758000.0.
- Burning Rock Biotech's Non-Current Receivables rose 828.57% to $758000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $758000.0, marking a year-over-year increase of 828.57%. This contributed to the annual value of $749000.0 for FY2023, which is 121.62% up from last year.
- Latest data reveals that Burning Rock Biotech reported Non-Current Receivables of $758000.0 as of Q3 2024, which was up 828.57% from $732000.0 recorded in Q2 2024.
- Over the past 5 years, Burning Rock Biotech's Non-Current Receivables peaked at $758000.0 during Q3 2024, and registered a low of $32000.0 during Q4 2020.
- Over the past 5 years, Burning Rock Biotech's median Non-Current Receivables value was $704000.0 (recorded in 2023), while the average stood at $532615.4.
- In the last 5 years, Burning Rock Biotech's Non-Current Receivables soared by 36866.67% in 2022 and then plummeted by 80.75% in 2024.
- Over the past 5 years, Burning Rock Biotech's Non-Current Receivables (Quarter) stood at $32000.0 in 2020, then surged by 368.75% to $150000.0 in 2021, then surged by 393.33% to $740000.0 in 2022, then rose by 1.22% to $749000.0 in 2023, then increased by 1.2% to $758000.0 in 2024.
- Its Non-Current Receivables was $758000.0 in Q3 2024, compared to $732000.0 in Q2 2024 and $737000.0 in Q1 2024.